Seth Ian Rosenthal MD

Pathology•Lexington, MA

Dermatopathology, Anatomic Pathology, Clinical Pathology

Laboratory of Dermatopathology

Join to View Full Profile

1 Cranberry HlSte 105Lexington, MA 02421
Phone+1 800-325-7284
Fax+1 205-579-9387

Summary

I am a board certified Dermatopathologist practicing in the Boston area.

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Dermatopathology, 2002 - 2003
University of Texas M.D. Anderson Cancer CenterSelective Pathology, 2001 - 2002
Albany Medical CenterResidency, Pathology-Anatomic and Clinical, 1997 - 2001
University of Alabama HospitalInternship, Transitional Year, 1996 - 1997
Albany Medical CollegeClass of 1996
Columbia UniversityPremedical Post baccalaureate Program, 1990 - 1991
University of PennsylvaniaB.A., Religious Studies, 1985 - 1988

Certifications & Licensure

FL State Medical License 2003 - 2027
MA State Medical License 2007 - 2027
WA State Medical License 2024 - 2027
AZ State Medical License 2024 - 2026
CA State Medical License 2024 - 2026
CT State Medical License 2008 - 2026
PA State Medical License 2008 - 2026
NJ State Medical License 2009 - 2025
NY State Medical License 2000 - 2025
American Board of Pathology Anatomic Pathology
American Board of Pathology Dermatopathology
Join now to see all

Publications & Presentations

PubMed

Tender Nonhealing Lesion on the Leg.
Austinn C Miller, Mojahed Mohammad K Shalabi, Stephen K Tyring, Seth Rosenthal, David J Cohen
Cutis. 2022-09-01
12 citations
Pyodermatitis-pyostomatitis vegetans associated with asymptomatic inflammatory bowel disease
Erin M. Dodd, Justin Howard, Eugene D. Dulaney, Seth I. Rosenthal, Michelle R. Wanna
International Journal of Dermatology. 2017-05-05
8 citations
Squamomelanocytic tumor: a case report and further insights into its possible histogenesis.
George Jour, Alberto Paniz-Mondolfi, Jason Reidy, Brienne D. Cressey, Seth Rosenthal
The American Journal of Dermatopathology. 2014-06-01

Journal Articles

Squamo-melanocytic tumor: A case report and further insights into its possible histogenesis.
Jour G, Paniz Mondolfi A, Reidy J, Cressey B, Rosenthal S, Am J Dermatopathol, 5/6/2013
Dermal Pleomorphic Liposarcoma.
Tariq Al-Zaid, M.D., Gretchen Frieling, M.D., Seth Rosenthal, M.D., J Cutan Pathol, 4/15/2013
Erythema Elevatum Diutinum: Report of a Unique Case and Novel Treatment with Topical Dapsone Gel 5% (ACZONE).
Gretchen W. Frieling, M.D., Scott J.M. Lim, D.O., and Seth Rosenthal, M.D., J Drugs Dermatol, 4/1/2013
Validation of Anti-PHH3 Immunostain in Fibrohistiocytic Tumors: A Study of 96 Cases.
G. Jour, A.P. Paniz, D. Lucido, and S. Rosenthal, 10/1/2012
Comparison of HER-2/neu Oncogene Amplification Detected by Fluorescence In Situ Hybridization in Lobular and Ductal Breast Cancer.
Rosenthal, S. I., Depowski, P. L., Sheehan, C. E., and Ross, J. S., Appl. Immunohistochem. Mol. Morphol., 1/1/2002
Loss of Expression of the PTEN Gene Protein Product is Associated with Poor Outcome in Breast Cancer.
PL Depowski, SI Rosenthal, JS Ross, Modern Pathology, 1/1/2001
Prognostic Significance of Topoisomerase II Alpha (Topo II) Expression in Breast Cancer.
PL Depowski, SI Rosenthal, TP Brien, S Stylos, RL Johnson, JS Ross, Modern Pathology, 1/1/2000
Join now to see all

Abstracts/Posters

High Grade Primary Cutaneous Angiosarcoma of Hip with Predominant Epithelioid Morphology.
A. Ahmad, M.D., M. Mahmoodi, M.D., A. Solky, M.D., S. Rosenthal, M.D., 48th annual ASDP meeting., 10/1/2011